Kim Isenberg Joins the Board of the National Organization for Rare Disorders
Recently, the National Organization for Rare Disorders (NORD) announced a significant addition to its Board of Directors, welcoming Kim Isenberg. Kim brings over three decades of extensive experience in public affairs and patient advocacy to the organization.
Isenberg's Expertise in the Rare Disease Community
Throughout her career, Isenberg has been a prominent leader in the rare disease space. She has worked tirelessly across the spectrum of health care, from policy development to the marketing strategies behind new treatment solutions. Her vast expertise significantly enhances NORD's mission to create meaningful change in the lives of those impacted by rare conditions.
A Passion for Advocacy
Kim Isenberg’s journey has been rooted in advocating for communities affected by rare diseases. Her dedication ensures that the unique challenges faced by these groups are acknowledged, and that their voices resonate throughout the health care system. Pamela Gavin, NORD's Chief Executive Officer, emphasized Kim’s vital role, stating, "Her insight and passion will be invaluable as we work to improve the lives of more than 30 million Americans affected by rare diseases."
Career Highlights and Contributions
Prior to her role at NORD, Isenberg served as the Head of Global Public Affairs at Sanofi's Rare Blood Disorders unit. Her efforts in patient access initiatives and her capability to shape advocacy efforts nationally have positioned her as a key figure in the rare disease community. She noted, "I am deeply honored to join NORD's Board of Directors and to contribute to the critical work of elevating patient voices."
Building Bridges Across Stakeholders
Kim Isenberg has proven adept at fostering partnerships across multiple sectors including industry, government, and nonprofit organizations. Her previous roles included Vice President of Policy and Advocacy at the Hemophilia Federation of America, where she collaborated closely with patient organizations dedicated to bleeding disorders.
Contributions Beyond Advocacy
Beyond her primary work, Isenberg also holds substantial governance experience. She has served on the boards of various organizations, including the University of Minnesota YMCA and the Cowles Dance Theatre, while also being actively involved with major public boards like the University of Minnesota Board of Regents. Her contributions extend into numerous community activities, illustrating her commitment to improving lives across the board.
Educational Background
Isenberg obtained her Bachelor of Arts in Speech Communication from the University of Minnesota, laying a solid foundation that has supported her extensive career in public policy and patient advocacy.
Learn More About NORD's Mission
The National Organization for Rare Disorders, founded in 1983, remains committed to advocating for the health and well-being of Americans affected by rare diseases. With a network of over 350 disease-specific member organizations, NORD continues to drive progress in research, policy-making, and care standards, ensuring that the needs of individuals with rare conditions are at the forefront of health care discussions.
Frequently Asked Questions
What is NORD?
The National Organization for Rare Disorders is a nonprofit that focuses on improving the health and lives of individuals affected by rare diseases.
Who is Kim Isenberg?
Kim Isenberg is a veteran in public affairs and patient advocacy, recently appointed to the NORD Board of Directors.
What experience does Kim Isenberg bring?
Isenberg has over 30 years of experience in health policy, advocacy, and drug development, making her an invaluable asset to NORD.
What is NORD's mission?
NORD aims to advocate for the rare disease community, working on research, care, and public policy efforts.
How can I learn more about NORD?
To learn more about NORD and its initiatives, visit their official website at rarediseases.org.
